logo
Share SHARE
FONT-SIZE Plus   Neg

Granules India's Paracetamol API Facility Completes U.S. FDA Inspection

Granules India Ltd., a fast growing pharmaceutical manufacturing company, announced its Paracetamol facility successfully passed a US FDA inspection without any 483 observations. The facility has the world's largest single API production line by volume.

Granules' four API facilities have successfully passed US FDA inspection in the past 12 months. All of Granules' facilities including its finished dosage and PFI facility are approved by leading regulatory agencies including the US FDA, EDQM, Health Canada and Korean FDA.

At the BSE, Granules India shares are currently trading at Rs.397.50, up 0.33 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

0 Articles
Editors Pick
Google has been fined a hefty 2.42 billion euros or $2.7 billion by the European Commission for breaching EU antitrust rules. The Commission ruled that Google has abused its market dominance as a search engine by giving illegal advantage to its own comparison shopping service. Japanese game maker Nintendo announced its plans to launch Super NES Classic Edition, the standalone mini console, which will feature 21 pre-installed classic games. The Mini 16-Bit System is expected to hit the stores on September 29 for $79.99. Best Inc., a 23.4 percent owned by e-commerce major Alibaba Group, filed for Initial Public Offering in the U.S. According to the filing, Best expects to offer $750 million american depository shares.
comments powered by Disqus
Follow RTT